The Procter & Gamble Company PG SPX
Company Overview
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Why Investors Should Care
Generates a return on equity of 31.1%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 22.9%.
Maintains a net profit margin of 19.2%.
Offers a dividend yield of 2.85%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jun 2025 Revenue of $84.28B (+0.3% YoY); net profit $15.97B.
- Trailing 12 Months Year-on-year growth — revenue +7.4%, earnings +5.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.4%, profit CAGR 1.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.36% |
| 1 Year: | 7.40% |
Compounded Profit Growth
| 5 Years: | 1.66% |
| 1 Year: | 5.80% |
Stock Price Performance
| 1 Year: | -2.26% |
| 6 Months: | +4.48% |
| 3 Months: | +2.51% |
| 1 Month: | -1.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.24 · Neutral
P/E of 21.36 is above the sector median of 20.95 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 31.1%.
- Healthy ROCE of 22.9%.
- Attractive dividend yield of 2.85%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PG The Procter & Gamble Company SPX | 146.08 | 21.36 | $340.16B | 2.85% | 22.93% | 31.11% | 0.36% | 1.66% |
| 2 | WMT Walmart Inc. SPX | 113.70 | 40.04 | $904.83B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 921.75 | 46.46 | $408.78B | 0.60% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 83.08 | 26.13 | $357.45B | 2.57% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PM Philip Morris International Inc. SPX | 175.95 | 24.78 | $274.23B | 3.19% | 34.03% | -113.55% | -1.69% | 3.57% |
| 6 | PEP PepsiCo, Inc. NDXSPX | 135.45 | 21.23 | $185.13B | 4.10% | 15.41% | 43.88% | 4.93% | 2.11% |
| 7 | MO Altria Group, Inc. SPX | 70.16 | 14.65 | $117.16B | 5.89% | 38.27% | - | 1.24% | -1.89% |
| 8 | MNST Monster Beverage Corporation NDXSPX | 98.00 | 47.34 | $95.84B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
| 9 | MDLZ Mondelez International, Inc. NDXSPX | 58.80 | 29.11 | $75.48B | 3.18% | 7.15% | 10.16% | 0.40% | -0.58% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 16.65B | 17.39B | 16.28B | 16.50B | 16.69B | 17.44B | 16.46B | 17.09B | 17.80B | 18.24B | 17.21B | 17.70B | 19.32B | 19.75B | 18.11B | 20.34B | 20.95B | 19.38B | 20.61B | 20.77B | 20.07B | 21.87B | 21.44B | 20.20B | 21.74B | 21.88B | 19.78B | 22.39B | 22.21B | 21.23B |
| Operating Income | 3.02B | 812.00M | 3.77B | 3.85B | 3.32B | 2.50B | 3.77B | 3.88B | 3.36B | 2.95B | 3.65B | 3.92B | 3.21B | 2.59B | 3.55B | 3.90B | 3.23B | -5.19B | 4.29B | 4.48B | 3.45B | 3.48B | 5.28B | 5.38B | 3.79B | 5.02B | 5.17B | 4.02B | 4.94B | 4.79B | 4.25B | 5.77B | 4.43B | 4.46B | 5.80B | 5.74B | 4.56B | 5.86B | 5.37B | 4.58B |
| Net Income | 2.15B | 521.00M | 2.60B | 3.21B | 2.75B | 1.95B | 2.71B | 7.88B | 2.52B | 2.21B | 2.85B | 2.50B | 2.51B | 1.89B | 3.20B | 3.19B | 2.75B | -5.24B | 3.59B | 3.72B | 2.92B | 2.80B | 4.28B | 3.85B | 3.27B | 4.11B | 4.22B | 3.35B | 3.94B | 3.93B | 3.40B | 4.52B | 3.47B | 3.75B | 3.96B | 4.63B | 3.77B | 4.75B | 4.32B | 3.93B |
| Diluted EPS | 0.75 | 0.18 | 0.91 | 1.12 | 0.97 | 0.69 | 0.96 | 2.88 | 0.93 | 0.82 | 1.06 | 0.93 | 0.95 | 0.72 | 1.22 | 1.22 | 1.04 | -2.12 | 1.36 | 1.41 | 1.12 | 1.07 | 1.63 | 1.47 | 1.26 | 1.61 | 1.66 | 1.33 | 1.57 | 1.59 | 1.37 | 1.83 | 1.40 | 1.52 | 1.61 | 1.88 | 1.54 | 1.95 | 1.78 | 1.63 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 79.26B | 76.69B | 77.57B | 81.10B | 28.40B | 29.20B | 29.40B | 70.75B | 65.30B | 65.06B | 66.83B | 67.68B | 70.95B | 76.12B | 80.19B | 82.01B | 84.04B | 84.28B |
| Operating Income | 15.98B | 15.37B | 15.73B | 15.49B | 13.04B | 13.82B | 13.91B | 11.05B | 13.44B | 13.77B | 13.36B | 5.49B | 15.71B | 17.99B | 17.81B | 18.13B | 18.55B | 20.45B |
| Net Income | 12.07B | 13.44B | 12.74B | 11.80B | 10.76B | 11.31B | 11.64B | 7.04B | 10.51B | 15.33B | 9.75B | 3.90B | 13.03B | 14.31B | 14.74B | 14.65B | 14.88B | 15.97B |
| Diluted EPS | 3.64 | 4.26 | 4.11 | 3.93 | 3.66 | 3.86 | 4.01 | 2.44 | 3.69 | 5.59 | 3.67 | 1.43 | 4.96 | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 |
| R&D Expense | - | - | - | 2.00B | 2.00B | 1.90B | 1.90B | 2.00B | 1.90B | 1.90B | 1.90B | 1.90B | 1.80B | 1.90B | 2.00B | 2.00B | 2.00B | 2.10B |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2007 | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 143.99B | 134.83B | 128.17B | 138.35B | 132.24B | 139.26B | 144.27B | 129.50B | 127.14B | 120.41B | 118.31B | 115.09B | 120.70B | 119.31B | 117.21B | 120.83B | 122.37B | 125.23B |
| Total Equity | 67.01B | 69.78B | 63.38B | 61.44B | 68.00B | 64.03B | 68.71B | 69.98B | 63.05B | 57.98B | 55.78B | 52.88B | 47.58B | 46.88B | 46.65B | 46.85B | 47.06B | 50.56B | 52.28B |
| Cash & Equivalents | 5.35B | 3.31B | 4.78B | 2.88B | 2.77B | 4.44B | 5.93B | 8.55B | 6.84B | 8.10B | 5.57B | 2.57B | 4.24B | - | - | - | - | - | - |
| Long Term Debt | - | - | 20.65B | 21.36B | 22.03B | 21.08B | 19.11B | 19.81B | 18.33B | 18.95B | 18.04B | 20.86B | 20.39B | 23.54B | 23.10B | 22.85B | 24.38B | 25.27B | 25.00B |
| Total Liabilities | - | - | 71.45B | 66.73B | 70.35B | 68.21B | 70.55B | 74.29B | 66.44B | 69.15B | 64.63B | 65.43B | 67.52B | 73.82B | 72.65B | 70.35B | 73.76B | 71.81B | 72.95B |
| Current Liabilities | - | - | 30.90B | 24.28B | 27.29B | 24.91B | 30.04B | 33.73B | 29.79B | 30.77B | 30.21B | 28.24B | 30.01B | 32.98B | 33.13B | 33.08B | 35.76B | 33.63B | 36.06B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.01B | 14.92B | 16.13B | 13.33B | 13.28B | 14.87B | 13.96B | 14.61B | 15.44B | 12.75B | 14.87B | 15.24B | 17.40B | 18.37B | 16.72B | 16.85B | 19.85B | 17.82B |
| Investing Cash Flow | -2.55B | -2.35B | -597.00M | -3.48B | -1.09B | -6.29B | -4.10B | -2.89B | -5.58B | -6.68B | -3.51B | -3.49B | 3.04B | -2.83B | -4.42B | -3.50B | -3.50B | -3.82B |
| Financing Cash Flow | -14.84B | -10.81B | -17.31B | -10.12B | -10.41B | -7.07B | -7.28B | -13.02B | -9.21B | -8.57B | -14.38B | -9.99B | -8.37B | -21.53B | -14.88B | -12.15B | -14.86B | -14.04B |
| Capital Expenditure | -3.05B | -3.24B | -3.07B | -3.31B | -3.96B | -4.01B | -3.85B | -3.74B | -3.31B | -3.38B | -3.72B | -3.35B | -3.07B | -2.79B | -3.16B | -3.06B | -3.32B | -3.77B |
| Free Cash Flow | 11.96B | 11.68B | 13.06B | 10.02B | 9.32B | 10.87B | 10.11B | 10.87B | 12.12B | 9.37B | 11.15B | 11.89B | 14.33B | 15.58B | 13.57B | 13.79B | 16.52B | 14.04B |
| Share Buybacks | 10.05B | 6.37B | 6.00B | 7.04B | 4.02B | 5.99B | 6.00B | 4.60B | 4.00B | 5.20B | 7.00B | 5.00B | 7.41B | 11.01B | 10.00B | 7.35B | 5.01B | 6.50B |
| Dividends Paid | 4.66B | 5.04B | 5.46B | 5.77B | 6.14B | 6.52B | 6.91B | 7.29B | 7.44B | 7.24B | 7.31B | 7.50B | 7.79B | 8.26B | 8.77B | 9.00B | 9.31B | 9.87B |
Ratios (Annual)
Figures in %.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 20.2% | 20.0% | 20.3% | 19.1% | 45.9% | 47.3% | 47.3% | 15.6% | 20.6% | 21.2% | 20.0% | 8.1% | 22.1% | 23.6% | 22.2% | 22.1% | 22.1% | 24.3% |
| Net Margin % | 15.2% | 17.5% | 16.4% | 14.5% | 37.9% | 38.7% | 39.6% | 9.9% | 16.1% | 23.6% | 14.6% | 5.8% | 18.4% | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% |
| ROE % | 17.3% | 21.2% | 20.7% | 17.3% | 16.8% | 16.5% | 16.6% | 11.2% | 18.1% | 27.5% | 18.4% | 8.2% | 27.8% | 30.7% | 31.5% | 31.1% | 29.4% | 30.6% |
| ROCE % | - | 14.8% | 15.1% | 14.0% | 12.1% | 12.6% | 12.6% | 11.1% | 13.9% | 15.3% | 14.8% | 6.4% | 17.9% | 20.9% | 21.2% | 21.3% | 20.9% | 22.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.03% | 187.03M | $27.55B |
| 2 | Vanguard Capital Management LLC | 6.49% | 151.05M | $22.25B |
| 3 | State Street Corporation | 4.35% | 101.25M | $14.92B |
| 4 | Geode Capital Management, LLC | 2.77% | 64.40M | $9.49B |
| 5 | Vanguard Portfolio Management LLC | 2.70% | 62.85M | $9.26B |
| 6 | Morgan Stanley | 2.11% | 49.22M | $7.25B |
| 7 | Charles Schwab Investment Management, Inc. | 1.78% | 41.36M | $6.09B |
| 8 | JPMORGAN CHASE & CO | 1.43% | 33.20M | $4.89B |
| 9 | Price (T.Rowe) Associates Inc | 1.38% | 32.09M | $4.73B |
| 10 | FMR, LLC | 1.32% | 30.71M | $4.52B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PG
Procter & Gamble (NYSE:PG) Stock Price Down 1.5% - Here's What Happened - MarketBeat
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQbWRfREpsSWVmbHJIWmx0Q0daVmx1SGJGUW5sdHlSNkRSeUF6V0VRLVk0X0ZUaS1KRm1yY1lscl95ZXB6dmtyV2RRSXFod0hXN1VISVJHZENtN1hZVG1yVWo5VXh5NXBaU29YRGhwdjg3RE9FaDZ6aHota0M5eVZxUERRZ1JEbkFlYlNTT3…
What You Need To Know Ahead of Procter & Gamble's Earnings Release - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNS0xidkpTSTN2cG8wSElacG5XYjdQYVBQV0Itb0FEdFd5VTgxb2lkWEJCNDhrRUdpM3ZmZ1BQZGllYWsxQ2RsN0xHcXlFbThpeVVlS3l5Z2IwTWJCbWFEdVpiWU1lQmptWXlOazVrbnNPX3piQkZiLXRlV1R1Q0t5clZxb2hwanZ4c1V4OT…
How to Buy Procter & Gamble Stock (PG) in 2026 - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQQlZvdjA5bkpyQ3VJekpzRzM2b0lJSFA1aW83QjdLX000YXdMYU9JLWxxODVFTjRuQ1YxRW9CSmdGVUxydDZ5SEV6c0NiYmg4RDlka1k2LTdGaDRJZlI4aXg1eWxkSjZCVElYeExPTFNWWnZKRF9uWTE3d243U0xDZmVGaE9TS25qN3EzLU…
Procter & Gamble (PG) Stock Still Looks Below Fair Value Today - simplywall.st
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNclBnVlFjU25PY1dMVmJnNTlCbFQ3S3hTdGVtcUZ0TmhrQkNnT1RzTHF1dk1iblZOekJaX1A1UFZPUEl1YmJFdFg3aHlzcmlXRHhzTmhyMWRPNmNTYXhCLXRXT1BaRi1KZXRTQmJxbllHNHgyNHJOLXZvSk5lSkJZd2k1TENBVnVmQk1XRS…
Procter & Gamble (PG) Declares Quarterly Dividend of $1.0885 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNTy1sdG54NWwzN04wZlZxVXdQa0pNUVF0SkJZOGtQZmlGSGs0UjdyZFoxZ2xpcmxXeXBEY2N4VVhSWDNBbUZuWlA0eV9HY2hsdG5FR1EzYmhaREJXZzBQa2J2TGk1ZHc5aGk2V0pXSEswYnZhWDZwU292MHJQeXRnVzB0aElUckxzZVpPTE…
Procter & Gamble vs PepsiCo: The Better Stock For Passive Income Investors - 24/7 Wall St.
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOU0xBamZlWmw5TXdBb3EzTVRoNVpsMDVxa1o1bHRUWFFucUo4QWNtNVJqVUhoc0UxNVdVbXlLbHBVU0R4U2NwckZnVkhOWUZ6RGU4WkZzTGZJalBlRFFtalRMLTlaVFJVdHNzbGR2Z1FFQ3g3YndSYVFESFQ4SU5jNlFmQ1lzeGN5TGdfbk…
PG — Frequently Asked Questions
What is the current share price of The Procter & Gamble Company (PG)?
As of 2026-07-14 21:23 PDT, The Procter & Gamble Company (PG) trades at $146.08 on NYSE. Its 52-week range is $136.04 to $165.95.
What is the market capitalisation of PG?
The Procter & Gamble Company (PG) has a market capitalisation of $340.16B on NYSE.
What is the P/E ratio of PG?
PG trades at a trailing price-to-earnings (P/E) ratio of 21.36. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 6.48.
Does PG pay a dividend?
The Procter & Gamble Company (PG) currently offers a dividend yield of 2.85%.
What is the return on equity (ROE) of PG?
PG has a return on equity (ROE) of 31.11%. Its return on capital employed (ROCE) is 22.93%.
Is PG a good stock to buy?
This page provides a data-driven analysis of The Procter & Gamble Company (PG), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.